SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia

<i>SLCO1B1</i> Variants and Statin-Induced Myopathy — A Genomewide Study

New England Journal of Medicine · 2008 · 2K citations · Full text

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

Roger R. Williams, Steven C. Hunt, Mary Catherine Schumacher et al. · The American Journal of Cardiology · 1993 · 563 citations

Metabolic Syndrome, Lipid Disorder, Genetic Testing +11

The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects

Deepak Voora, Svati H. Shah, Ivan Spasojević et al. · Journal of the American College of Cardiology · 2009 · 502 citations

Genetics, Genetic Factor, Medicine +3

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

Marja K. Pasanen, Mikko Neuvonen, Pertti J. Neuvonen et al. · Pharmacogenetics and Genomics · 2006 · 461 citations

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

Marja K. Pasanen, Hanna Fredrikson, Pertti J. Neuvonen et al. · Clinical Pharmacology & Therapeutics · 2007 · 428 citations